Thursday, November 26, 2009

Bipolar Home>
News>
FDA panel recommends new bipolar, schizophrenia drug

Font size
- A
- A
- A
Email This

Bookmark

Save

Exclusive savings on ADHD products and much, much more! Start saving today!

FDA panel recommends new bipolar, schizophrenia drug

(Medical News Today) UPDATED 2009-07-31

An expert panel that advises the U.S. Food and Drug Administration (FDA) has voted unanimously to recommend a new drug for bipolar I disorder and schizophrenia. The drug, Saphris, was found to safe and effective for the acute treatment of manic or mixed episodes associated with bipolar I disorder, as well as for the acute treatment of schizophrenia in adults. If eventually approved by the FDA, Saphris would be the first drug approved for both indications. Read full story >

See all Bipolar News

Related: Saphris

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Non-Profit Affiliates:

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on BipolarConnect.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.